Emil Ruusuvuori determined to publicly reveal why he took an abrupt break from tennis final yr because the 26-year-old reveals he battled "recurring panic assaults" and easily wanted time away from the sport to handle his situation.
In early 2024, the Finnish tennis participant made his maiden ATP closing in Hong Kong, wherein he fell quick to Andrey Rublev in two units. Within the subsequent half a yr, he didn't get pleasure from a lot success as he was largely exiting tournaments within the very early phases.
Firstly of the summer season on exhausting courts, Ruusuvuori misplaced within the Washington second spherical. The previous world No. 37 didn't seem in any tournaments in the remainder of the 2024 season.
His break from tennis lasted half a yr, till he returned to tennis on the Tenerife Challenger in February.
Ruusuvuori: In 2024, I suffered from recurring and worsening panic assaults
"I had my first panic assaults 4 years in the past already. I can hardly keep in mind something in regards to the final match of Wimbledon final summer season, and the scenes are nonetheless coming – the final ones I skilled on my journey to South Korea," the 26-year-old revealed in an Instagram publish.
"Final yr, I suffered from recurring and worsening panic assaults, and different psychological challenges each on and off the court docket. Because of this I took a break for six months from competing. I haven't touched a tennis membership in 4.5 months – I merely couldn't go on the court docket."
It has been three months since Ruusuvuori made a comeback to tennis. And he’s telling his story as a result of he hopes it may well assist anyone.
"I hope that the message will get throughout and that I can emphasize the significance of caring for your psychological well-being. I hope after this I can focus even higher on my life and tennis profession," the Finn added.
View this publish on Instagram
At the moment, Ruusuvuori is ranked at No. 235 on the earth and has performed totally on the Challenger degree. Up to now, he’s solely 5-8 in 2025 with none notable outcomes.
